Publication
B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-? response to TLR9 triggering
Journal Paper/Review - Oct 1, 2010
Audigé Annette, Schlaepfer Erika, von Wyl Viktor, Miller Regina C, Vernazza Pietro, Nadal David, Speck Roberto F, SHCS
Units
PubMed
Citation
Type
Journal
Publication Date
Issn Electronic
Pages
Brief description/objective
Each cell in HIV-associated primary central nervous system lymphoma (PCNSL) harbors latent EBV. Notably, the triggering of TLR9, a key event in HIV pathogenesis, also promotes EBV latency and transformation. We hypothesized that because only a minority of HIV-infected patients develops PCNSL, their B cells exhibit aberrant signaling responses to TLR9 triggering. We found higher levels of IL-6, CD80, and CD86 expression at baseline in B cells of those patients than in B cells of matched controls, whereas TNF-a expression was lower. Notably, on TLR9 triggering with CpG 2006, CD80 and TNF-? were up-regulated to a lesser extent in B cells of the former than in those of matched controls. The reduced up-regulation of CD80 might be explained by its higher baseline expression resulting in a more blunted response rather than a specific deficit of the signaling response to TLR9 triggering. However, this cannot explain the blunted TNF-? response, which warrants further investigation. Finally, since increased IL-6 expression is linked to EBV-associated Hodgkin's lymphoma, the enhanced baseline expression of IL-6 might be important in the pathogenesis of PCNSL in HIV-infected patients.